Oligonucleotide–Based Drugs and Therapeutics – Preclinical and Clinical Considerations for Development
Autor N Ferrarien Limba Engleză Hardback – 6 sep 2018
Preț: 1319.27 lei
Preț vechi: 1388.71 lei
-5% Nou
Puncte Express: 1979
Preț estimativ în valută:
252.56€ • 259.74$ • 209.52£
252.56€ • 259.74$ • 209.52£
Carte tipărită la comandă
Livrare economică 20 februarie-06 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781118537336
ISBN-10: 1118537335
Pagini: 576
Dimensiuni: 152 x 229 x 32 mm
Greutate: 0.9 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 1118537335
Pagini: 576
Dimensiuni: 152 x 229 x 32 mm
Greutate: 0.9 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Scientists in the pharmaceutical and biotechnology industry, such as chemists, pharmaceutical scientists, and toxicologistsMedicinal chemists, biochemists, molecular chemists, nucleic acid chemists, chemical biologists
Pharmaceutical researchers, companies, and laboratories
Regulatory specialists and safety assessment professionals
Industry and academic professionals and advanced graduate students interested in novel therapeutics, antisense therapy, and oligonucleotides
Cuprins
Notă biografică
Descriere
Antisense-based drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer, diabetes, and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.